• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC HEART VALVES DIVISION MOSAIC MITRAL BIOPROSTHETIC HEART VALVE; HEART-VALVE, NON-ALLOGRAFT TISSUE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC HEART VALVES DIVISION MOSAIC MITRAL BIOPROSTHETIC HEART VALVE; HEART-VALVE, NON-ALLOGRAFT TISSUE Back to Search Results
Model Number 310-31
Device Problems Calcified (1077); Occlusion Within Device (1423)
Patient Problems Calcium Deposits/Calcification (1758); Edema (1820); Fatigue (1849); High Blood Pressure/ Hypertension (1908); Mitral Regurgitation (1964); Mitral Valve Stenosis (1965)
Event Date 04/01/2015
Event Type  Injury  
Manufacturer Narrative
(b)(4).Title: transcatheter, valve-in-valve transapical aortic and mitral valve implantation, in a high risk patient with aortic and mitral prosthetic valve stenoses citation: 2015 apr-jun;18(2):246-51.[doi: 10.4103/0971-9784.154493] authors: harish ramakrishna, patrick a.Devaleria1, john p.Sweeney, farouk mookaram month and year of publish used for event date.No unique device identifier (serial/lot) numbers were provided; without this information it cannot be determined whether this event has been previously reported.
 
Event Description
Medtronic received information via literature review that an (b)(6) male patient, who had two medtronic porcine bioprosthetic valves implanted 7 years earlier in the aortic (25-mm, serial numbers not provided) and mitral (31-mm, serial numbers not provided) positions, presented with severe aortic and mitral stenosis.A transesophageal echocardiogram (tee) revealed significant prosthetic valve disease.The aortic prosthesis had calcific and obstructed leaflets and elevated mean transvalvular gradient.The mitral prosthesis had calcific, obstructed and severely stenotic leaflets with mild mitral regurgitation.Left ventricular (lv) function was relatively well preserved however there was moderate to severe right ventricular (rv) enlargement and severe rv hypokinesis in conjunction with severe pulmonary hypertension.During the work-up period, the patient developed significant clinical deterioration with worsening fatigue, shortness of breath and edema.In a transcatheter intervention both the aortic and mitral prostheses were successfully replaced with a new non-medtronic prosthetic valves placed inside the diseased bioprosthetic valves.The patient was discharged six days post-operative with markedly improved functional status and acceptable prosthetic valve gradients.No additional adverse patient effects were reported.
 
Manufacturer Narrative
If information is provided in the future, a supplemental report will be issued.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
MOSAIC MITRAL BIOPROSTHETIC HEART VALVE
Type of Device
HEART-VALVE, NON-ALLOGRAFT TISSUE
Manufacturer (Section D)
MEDTRONIC HEART VALVES DIVISION
1851 e. deere ave.
santa ana CA 92705
Manufacturer (Section G)
MEDTRONIC STRUCTURAL HEART
8200 coral sea street ne
mounds view MN 55112
Manufacturer Contact
paula bixby
8200 coral sea street ne
mounds view, MN 55112
7635055378
MDR Report Key5300036
MDR Text Key33589657
Report Number2025587-2015-01321
Device Sequence Number1
Product Code LWR
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P990064
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional,literatur
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 11/16/2015
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model Number310-31
Device Catalogue Number310-31
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 11/16/2015
Initial Date FDA Received12/15/2015
Supplement Dates Manufacturer Received11/16/2015
Supplement Dates FDA Received09/19/2017
Was Device Evaluated by Manufacturer? No
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age00081 YR
-
-